CTM CRC Receives CRCA Excellence in Innovation Award for its Spin-out Company Carina Biotech


May 29, 2019 / News & Media Releases

The CRC for Cell Therapy Manufacturing (CTM CRC) is the proud recipient of a Cooperative Research Centres Association (CRCA) Excellence in Innovation Award for its spin-out company, Carina Biotech. The award was presented by the CRCA to CTM CRC and Carina at tonight’s Excellence in Innovation Awards Dinner, held at the Hilton Hotel during the CRCA Collaborate Innovate 2019 conference.

Read More

Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Wounds


May 31, 2018 / News & Media Releases

Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that it has received positive data demonstrating the efficacy of its Cymerus™ mesenchymal stem cells (MSCs) in a preclinical model of diabetic wounds. The studies were conducted independently by the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC) and were designed to compare cells from various sources.

Read More